Tenet Healthcare (NYSE:THC) Shares Gap Down – Time to Sell?

Posted by Brian Himes on Jul 14th, 2026

Tenet Healthcare Corporation (NYSE:THC – Get Free Report) gapped down prior to trading on Tuesday . The stock had previously closed at $194.81, but opened at $185.00. Tenet Healthcare shares last traded at $185.1310, with a volume of 437,026 shares trading hands.

Analysts Set New Price Targets

A number of analysts recently issued reports on the company. Weiss Ratings cut Tenet Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, June 2nd. Robert W. Baird decreased their price target on Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 5th. Barclays raised their price objective on shares of Tenet Healthcare from $238.00 to $240.00 and gave the company an “overweight” rating in a research report on Wednesday, July 8th. Wall Street Zen lowered shares of Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, May 11th. Finally, KeyCorp lowered their target price on shares of Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating on the stock in a research note on Friday, May 1st. Eighteen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $245.37.

Check Out Our Latest Stock Report on Tenet Healthcare

Tenet Healthcare Price Performance

The firm has a market capitalization of $15.72 billion, a P/E ratio of 9.48, a price-to-earnings-growth ratio of 1.68 and a beta of 1.27. The company has a debt-to-equity ratio of 1.96, a quick ratio of 1.30 and a current ratio of 1.36. The business has a 50 day simple moving average of $184.26 and a two-hundred day simple moving average of $197.65.

Tenet Healthcare (NYSE:THC – Get Free Report) last issued its quarterly earnings data on Thursday, April 30th. The company reported $4.82 EPS for the quarter, topping the consensus estimate of $4.21 by $0.61. The company had revenue of $5.37 billion during the quarter, compared to analyst estimates of $5.39 billion. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.Tenet Healthcare’s revenue was up 2.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $4.36 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. On average, sell-side analysts expect that Tenet Healthcare Corporation will post 17.61 EPS for the current fiscal year.

Insider Buying and Selling at Tenet Healthcare

In other news, Director Nadja West sold 3,000 shares of the firm’s stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total transaction of $532,050.00. Following the sale, the director owned 24,805 shares in the company, valued at approximately $4,399,166.75. This trade represents a 10.79% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director J Robert Kerrey sold 5,638 shares of the company’s stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $174.52, for a total transaction of $983,943.76. Following the completion of the transaction, the director owned 16,804 shares of the company’s stock, valued at $2,932,634.08. This trade represents a 25.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 0.97% of the company’s stock.

Institutional Trading of Tenet Healthcare

Several hedge funds and other institutional investors have recently bought and sold shares of THC. Triumph Capital Management purchased a new position in shares of Tenet Healthcare during the third quarter worth approximately $25,000. Activest Wealth Management bought a new position in shares of Tenet Healthcare during the 4th quarter valued at $26,000. Elyxium Wealth LLC purchased a new position in Tenet Healthcare in the 4th quarter worth $29,000. Canada Pension Plan Investment Board bought a new stake in Tenet Healthcare in the second quarter worth $35,000. Finally, Meeder Asset Management Inc. boosted its position in Tenet Healthcare by 146.2% during the fourth quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock valued at $38,000 after buying an additional 114 shares during the period. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Tenet Healthcare Company Profile

(Get Free Report)

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.